0000000000222352

AUTHOR

D. Yuste-vila

showing 2 related works from this author

Management of returned anti-neoplastic treatments and their reuse in oncology patients

2009

Abstract Objective Analyse the profile of parenteral preparation and treatment (anti-neoplastic and supplementary) that were dispensed and returned to the Pharmacy Department, the reasons why they were not administered, their reuse and the associated direct costs. Method Longitudinal study over 8 months (October 2004-May 2005) in a tertiary hospital with centre for preparing anti-neoplastic agents (including supplementary treatment) in its Pharmacy Department. The variables studied, downloaded from the Oncofarm® application, are as follows: a) patients and diagnostics; b) returned treatments, classified by reason returned, pharmaco-therapeutic scheme, cycle, and day; c) returned preparation…

Indirect costsmedicine.medical_specialtybusiness.industryInternal medicineSafety criteriaMedicineOncology patientsPharmacybusinessAnti neoplasticLevofolinic acidConfidence intervalFarmacia Hospitalaria (English Edition)
researchProduct

Gestión de la devolución de tratamientos antineoplásicos y de su reutilización en pacientes oncológicos

2009

Objective: Analyse the profi le of parenteral preparation and treatment (anti-neoplastic and supplementary) that were dispensed and returned to the Pharmacy Department, the reasons why they were not administered, their reuse and the associated direct costs. Method: Longitudinal study over eight months (October 2004-May 2005) in a tertiary hospital with centre for preparing anti-neoplastic agents (including supplementary treatment) in its Pharmacy Department. The variables studied, downloaded from the Oncofarm® application, are as follows: a) patients and diagnostics; b) returned treatments, classifi ed by reason returned, pharmaco-therapeutic scheme, cycle and day; c) returned preparations …

Pharmacologymedicine.medical_specialtyIndirect costsbusiness.industryInternal medicinemedicineSafety criteriaPharmacybusinessLevofolinic acidSurgeryFarmacia Hospitalaria
researchProduct